Satya Nadella has unveiled Researcher and Analyst, two advanced reasoning agents in Microsoft 365 Copilot, enabling secure, ...
Enhanced mobility: The Dell Pro 7-in-1 USB-C Travel Hub offers easy connectivity in any remote or client location, and the ...
Affinity now connects with Canva’s AI Studio, integrating tools such as Generative Fill, Expand & Edit, and Remove Background ...
India's entertainment industry is embracing AI, creating its first AI-driven series and films, blending technology with ...
Ad-supported and free streaming television platforms continue to grow in usage among U.S. households, according ... Read More ...
Qilin ransomware gang has claimed a data breach of Japan’s Super Value Co., leaking internal and HR files and putting Japan’s ...
Glen Powell's Smash Kitchen brand is taking off, introducing organic condiments and cooking oils that make healthy eating ...
Helex has raised $3.5m in a seed funding round spearheaded by pi Ventures to advance non-viral gene therapies for kidney ...
With Bon Jovi Bon’s recovery from vocal chord surgery, the 2026 tour promises a celebration of endurance, resilience and ...
Company Also Publishes Separate QA with New CFO AUSTIN, TEXAS / ACCESS Newswire / October 31, 2025 / Interactive Strength Inc. (NASDAQ:TRNR) ("TRNR" or the "Company"), maker of innovative specialty ...
Pharmaceutical Technology on MSN
Health Canada grants NOC for AstraZeneca’s breast cancer therapy
Health Canada has issued a Notice of Compliance (NOC) for AstraZeneca’s HER2-directed antibody drug conjugate (ADC) Enhertu.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback